Manuel Vogt
Family Medicine · San Antonio, TXNPI 1962849612
Payments from drug & device makers
Across 239 payments — averaging $91.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Abbott$985
- Novo Nordisk$711
- Lilly USA, LLC$592
- Pfizer$418
- Amgen$332
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$14,00064%
- Travel & lodging$2,70912%
- Food & beverage$5,10523%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $17,221 |
| Abbott | 21 | $985 |
| Novo Nordisk | 54 | $711 |
| Lilly USA, LLC | 39 | $592 |
| Pfizer | 14 | $418 |
| Amgen | 25 | $332 |
| GSK | 6 | $300 |
| AstraZeneca | 7 | $168 |
| Gilead | 7 | $162 |
| Corcept Therapeutics | 2 | $122 |
| Actelion Pharmaceuticals US, Inc. | 1 | $111 |
| Merck | 6 | $103 |
| Boehringer Ingelheim | 4 | $81 |
| Novartis | 4 | $72 |
| Astellas Pharma US Inc | 4 | $67 |
| AbbVie(2 entities) | 4 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Amarin Pharma, Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Bayer | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Kvk-tech, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Intuity Medical Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,768
- DA VINCI SP$6,150
- FreeStyle Libre$311
- FREESTYLE LIBRE 3$270
- AREXVY$246
- KISUNLA$125
- ELIQUIS$121
- Korlym$106
How this compares
$21,822 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $73,363 |
| MounjaroTirzepatide | 48 | $57,846 |
| JardianceEmpagliflozin | 22 | $29,570 |
| EliquisApixaban | 19 | $20,526 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 25 | $8,052 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $7,061 |
| Atorvastatin Calcium | 104 | $1,048 |
| Levothyroxine Sodium | 59 | $986 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 13 | $929 |
| Ipratropium Bromide | 21 | $618 |
| Ibandronate Sodium | 21 | $607 |
| Losartan Potassium | 30 | $560 |
| Amlodipine Besylate | 82 | $523 |
| Gabapentin | 33 | $517 |
| Rosuvastatin Calcium | 41 | $509 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $711 | $73,36346 claims |
| Lilly USA, LLCMounjaro | $592 | $57,84648 claims |
| Boehringer IngelheimJardiance | $81 | $29,57022 claims |
| PfizerEliquis, Abrysvo | $418 | $28,57844 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in San Antonio
- Douglas DenhamSan Antonio$68.5M
- George AtieeSan Antonio$19.9M
- Leonel ReyesSan Antonio$4.3M
- Brian MacgillivraySan Antonio$3.2M
- Juan GarzaSan Antonio$2.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.